Illumina Genomics Podcast podcast

Does finding a rare mutation accomplish anything?

0:00
4:34
Manda indietro di 15 secondi
Manda avanti di 15 secondi
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.

Altri episodi di "Illumina Genomics Podcast"